Blog
6 FMV Myths Debunked
Each valuation analyzes the arrangement to determine Fair Market Value (FMV) compensation with consideration of the cost, income and market approaches. Read this article for 5 common FMV myths.
Articles by: Katie Tarr
Each valuation analyzes the arrangement to determine Fair Market Value (FMV) compensation with consideration of the cost, income and market approaches. Read this article for 5 common FMV myths.
Over the course of the COVID-19 pandemic, the trend of… Read more »
On November 19, the Center for Medicare & Medicaid Services… Read more »
As seen in Modern Healthcare Written by Alex Kacik featuring… Read more »
The 2020 AHLA Fraud and Compliance Forum provided many COVID… Read more »
As regulations and requirements for transparent interactions between pharmaceutical, medical device and biotechnology companies (collectively “life sciences organizations” or “LSOs”), and healthcare professionals (“HCPs”) continue to evolve, certain patterns are emerging. It is becoming increasingly important to protect prescribers and companies by ensuring that transactions are commercially reasonable and FMV compliant.